Development and validation of a fluorimetric method to determine curcumin in lipid and polymeric nanocapsule suspensions

Brazilian Journal of Pharmaceutical Sciences

Volumn 46, Issue 2, 2010, Pages 219-226

  Mazzarino, Letícia ^a   Bellettini, Ismael Casagrande ^a   Minatti, Edson ^a   Lemos Senna, Elenara ^a  

^a FEDERAL UNIVERSITY OF SANTA CATARINA   (Brazil)

Author keywords

Curcumin determination; Fluorimetric method quantitative analysis; Lipid nanocapsules evaluation; Polymeric nanocapsules evaluation

Indexed keywords

CURCUMIN; NANOCAPSULE; LIPID; POLOXAMER; POLYMER; SOLUTOL HS 15;

ACCURACY; ARTICLE; CALIBRATION; DRUG FORMULATION; DRUG SCREENING; DRUG STRUCTURE; FLUORESCENCE; SUSPENSION; VALIDATION PROCESS; DRUG DETERMINATION; FLUOROMETRY; LIMIT OF DETECTION; LIMIT OF QUANTITATION;

EID: 77956417657     PISSN: 19848250     EISSN: 21759790     Source Type: Journal    
DOI: 10.1590/S1984-82502010000200008     Document Type: Article

References (34)

1. ABDELLATEF, H. E.; EL-HENAWEE, M. M.; EL-SAYED, H. M.; AYAD, M. M. Spectrophotometric and spectrofluorimetric methods for analysis of acyclovir and acebutolol hydrochloride. Spectrochim. Acta A Mol. Biomol. Spectrosc., v.65, p.997-999, 2006.
2. AGGARWAL, B.; KUMAR, A.; BHARTI, A. Anticancer potential of curcumin: preclinical and clinical studies. Anticancer Res., v.23, p.363-398, 2003.
3. AKTAS, E.S.; ERSOY, L.; SAGIRH, O. A new spectrofluorimetric method for the determination of lisinopril in tablets. Farmaco, v.58, p.165-168, 2003.
4. ANTON, N.; BENOIT, J.; SAULNIER, P. Design and production of nanoparticles formulated from nano-emulsion templates - a review. J. Control. Release, v.128, p.185-199, 2008.
5. BISHT, S.; FELDMANN, G.; SONI, S.; RAVI, R.; KARIKARI, C.; MAITRA, A.; MAITRA, A. Polymeric nanoparticle-encapsulated curcumin (nanocurcumin): a novel strategy for human cancer therapy. J. Nanobiotechnology, v. 5, n. 3, 2007. Available at: 〈http://www.jnanobiotechnology.com/content/5/1/3〉. Accessed on: 27 feb. 2009.
6. BRASIL. Agência Nacional de Vigilância Sanitária. Resolução RE no 899, de 29 de maio de 2003 - Guia para validação de métodos analíticos e bioanalíticos. Available at: 〈http://www.anvisa.gov.br〉. Accessed on: 15 fev. 2009.
7. DÍAZ, A. N.; PEINADO, R. Fluorometric determination of curcumin in yogurt and mustard. J. Agric. Food Chem., v.40, p.56-59, 1992.
8. DULIEU, C.; BAZILE, D. Influence of lipid nanocapsules composition on their aptness to freeze-drying. Pharm. Res., v.22, p.285-292, 2005.
9. ERMER, J. Validation in pharmaceutical analysis. Part I: an integrated approach. J. Pharm. Biomed. Anal., v.24, p.755-767, 2001.
10. FESSI, H.; PUISIEUX, F.; DEVISSAGUET, J. P.; AMMOURY, N.; BENITA, S. Nanocapsule formation by interfacial deposition following solvent displacement. Int. J. Pharm., v.55, R1-R4, 1989.
11. FONSECA, C.; SIMÕES, S.; GASPAR, R. Paclitaxel-loaded PLGA nanoparticles: preparation, physicochemical characterization and in vitro anti-tumoral activity. J. Control. Release, v.83, p.273-286, 2002.
12. GREF, R.; DOMB, A.; QUELLEC, P.; BLUNK, T.; MÜLLER, R. H.; VERBAVATZ, J. M.; LANGER, R. The controlled intravenous delivery of drugs using PEG-coated sterically stabilized nanospheres. Adv. Drug Deliv., v.16, p.215-233, 1995.
13. GUPTE, A.; CIFTCI, K. Formulation and characterization of paclitaxel, 5-FU and paclitaxel + 5-FU microspheres. Int. J. Pharm., v.276, p.93-106, 2004.
14. HEATH, D.; PRUITT, M.; BRENNER, D.; ROCK, C. Curcumin in plasma and urine: quantitation by high-performance liquid chromatography. J. Chromatogr. B., v.783, p.287-295, 2003.
15. HEURTAULT, B.; SAULNIER, P.; PECH, B.; PROUST, J.; BENOIT, J. A novel phase inversion-based process for the preparation of lipid nanocarriers. Pharm. Res., v.19, p.875-880, 2002.
16. HEURTAULT, B.; SAULNIER, P.; PECH, B.; VENIER-JULIENNE, M.; PROUST, J.; PHAN-TAN-LUU, R.; BENOIT, J. The influence of lipid nanocapsule composition on their size distribution. Eur. J. Pharm. Sci., v.18, p.55-61, 2003.
17. INTERNATIONAL CONFERENCE ON HARMONIZATION. ICH. Validation of analytical procedures: text and methodology, Q2(R1), 2005. Available at: 〈http://www.ich.org〉. Accessed: 27 feb. 2009.
18. KHOPDE, S. M.; PRIYADARSINI, K. I.; PALIT, D. K.; MUKHERJEE, T. Effect of solvent on the excited-state photophysical properties of curcumin. Photochem. Photobiol., v.72, p.625-631, 2000.
19. MAHESHWARI, R.; SINGH, A.; GADDIPATI, J.; SRIMAL, R. Multiple biological activities of curcumin: a short review. Life Sci., v.78, p.2081-2087, 2006.
20. MEHNERT, W.; MÄDER, K. Solid lipid nanoparticles. Production, characterization and applications. Adv. Drug Deliv., v.47, p.165-196, 2001.
21. NAM, S.; NAM, H.; JOO, J.; BAEK, I.; PARK, J. Curcumin-loaded PLGA nanoparticles coating onto metal stent by electrophoretic deposition techniques. Bull. Korean Chem. Soc., v.28, p.397-402, 2007.
22. SHARMA, R.; MCLELLAND, H.; HILL, K.; IRESON, C.; EUDEN, S.; MANSON, M.; PIRMOHAMED, M.; MARNETT, L.; GESCHER, A.; STEWARD, W. Pharmacodynamic and pharmacokinetic study of oral curcuma extract in patients with colorectal cancer. Clin. Cancer Res., v.7, p.1894-1900, 2001.
23. SOU, K.; INENAGA, S.; TAKEOKA, S.; TSUCHIDA, E. Loading of curcumin into macrophages using lipid-based nanoparticles. Int. J. Pharm., v.352, p.287-293, 2008.
24. SYNG-AI, C.; KUMARI, A.; KHAR, A. Effect of curcumin on normal and tumor cells: role of glutathione and bcl-2. Mol. Cancer Ther., v.9, p.1101-1108, 2004.
25. TIYABOONCHAI, W.; TUNGPRADIT, W.; PLIANBANGCHANG, P. Formulation and characterization of curcuminoids loaded solid lipid nanoparticles. Int. J. Pharm., v.337, p.299-306, 2007.
26. TOMREN, M.; MÁSSON, M.; LOFTSSON, T.; TONNESEN, H. Studies on curcumin and curcuminoids XXXI. Symmetric and asymmetric curcuminoids: stability, activity and complexation with cyclodextrin. Int. J. Pharm., v.338, p.27-34, 2007.
27. TONNESEN, H. Solubility, chemical and photochemical stability of curcumin in surfactant solutions. Pharmazie, v.57, p.820-824, 2002.
28. TONNESEN, H.; MÁSSON, M.; LOFTSSON, T. Studies of curcumin and curcuminoids. XXVII. Cyclodextrin complexation: solubility, chemical and photochemical stability. Int. J. Pharm., v.244, p.127-135, 2002.
29. UNITED STATES PHARMACOPEIA. 30.ed. Validation of compendial procedures. Rockville: United States Pharmacopeial Convention, 2007. chap.1225, p.680-683.
30. 3+-tryptophan complex. J. Pharm. Biomed. Anal., v.43, p.393-398, 2007.
31. WANG, F.; HUANG, W.; WANG, Y. Fluorescence enhancement effect for the determination of curcumin with yttrium (III)-curcumin-sodium dodecyl benzene sulfonate system. Luminescence, v.128, p.110-116, 2008.
32. WANG, F.; WU, X.; WANG, F.; LIU, S.; JIA, Z.; YANG, J. The sensitive fluorimetric method for the determination of curcumin using the enhancement of mixed micelle. J. Fluoresc., v.16, p.53-59, 2006.
33. WANG, Y.; PAN, M.; CHENG, A.; LIN, L.; HO, Y., HSIEH, C.; LIN, J. Stability of curcumin in buffer solutions and characterization of its degradation products. J. Pharm. Biomed. Anal., v.15, p.1867-1876, 1997.
34. WITSCHI, C.; DOELKER, E. Residual solvents in pharmaceutical products: acceptable limits, influences on physicochemical properties, analytical methods and documented values. Eur. J. Pharm. Biopharm., v.43, p.215-242, 1997.